Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)

Amphastar Pharmaceuticals has reported Minority Interest for 4 years, with the latest figure at $45.2 million in Q2 2021.

• On a quarterly basis, Minority Interest changed N/A year-over-year to $45.2 million in Q2 2021; TTM through Jun 2021 was $45.2 million, a N/A change from a year earlier, with the FY2020 full-year figure at $46.4 million, up 0.55% from the prior year.
• Minority Interest was $45.2 million for Q2 2021 at Amphastar Pharmaceuticals, roughly flat from $45.4 million in the prior quarter.
• The five-year high for Minority Interest was $46.4 million in Q4 2020, with the low at $21.9 million in Q3 2018.
• Average Minority Interest over 4 years is $42.0 million, with a median of $45.3 million recorded in 2019.
• The sharpest annual moves came in 2019 and 2021: Minority Interest soared 102.47% in 2019, then dropped 1.0% in 2021.
• Over 4 years, Minority Interest stood at $31.9 million in 2018, then jumped by 44.6% to $46.2 million in 2019, then gained by 0.55% to $46.4 million in 2020, then declined by 2.56% to $45.2 million in 2021.
• The last three Minority Interest figures came in at $45.2 million (Q2 2021), $45.4 million (Q1 2021), and $46.4 million (Q4 2020), per Business Quant data.